SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 93 filers reported holding SAGE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,762 | -99.6% | 85,600 | +574.0% | 0.00% | +200.0% |
| Q3 2022 | $497,000 | -64.6% | 12,700 | -70.7% | 0.00% | -50.0% |
| Q2 2022 | $1,402,000 | -88.2% | 43,400 | -84.8% | 0.00% | -80.0% |
| Q2 2020 | $11,884,000 | -44.6% | 285,800 | -61.7% | 0.01% | -52.4% |
| Q1 2020 | $21,458,000 | +168.8% | 747,132 | +575.6% | 0.02% | +250.0% |
| Q4 2019 | $7,984,000 | +1916.2% | 110,591 | +3849.7% | 0.01% | – |
| Q3 2018 | $396,000 | -99.5% | 2,800 | -99.4% | 0.00% | -100.0% |
| Q2 2018 | $73,126,000 | +55.5% | 458,700 | +57.1% | 0.04% | -21.6% |
| Q1 2018 | $47,032,000 | +1145.2% | 292,000 | +1173.4% | 0.05% | +1175.0% |
| Q4 2017 | $3,777,000 | +576.9% | 22,931 | +106.6% | 0.00% | +300.0% |
| Q1 2015 | $558,000 | – | 11,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |